PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8811425-0	1996	3-Nitropropionic acid produces striatum selective lesions accompanied by iNOS expression.	3-nitropropionic acid	0-21	nitric oxide synthase 2	Rattus norvegicus	73-77	
24593790-6	2014	Moreover, Pur pretreatment blocked 3-NP-induced inflammatory biomarkers (NF-kappaB, TNF-alpha, and iNOS) and prevented the energy deficit (ATP reduction).	3-nitropropionic acid	35-39	nitric oxide synthase 2	Rattus norvegicus	99-103	
25675218-7	2015	Systemic administration of 3-NPA for 4 consecutive days impaired locomotor activity, decreased retention latencies in the passive avoidance task, decreased striatal, cortical and hippocampal ATP levels, increased oxidative stress, acetylcholinesterase (AChE) activity, cycloxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) expressions.	3-nitropropionic acid	27-32	nitric oxide synthase 2	Rattus norvegicus	297-328	
25675218-7	2015	Systemic administration of 3-NPA for 4 consecutive days impaired locomotor activity, decreased retention latencies in the passive avoidance task, decreased striatal, cortical and hippocampal ATP levels, increased oxidative stress, acetylcholinesterase (AChE) activity, cycloxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) expressions.	3-nitropropionic acid	27-32	nitric oxide synthase 2	Rattus norvegicus	330-334